Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Completed Phase 2 Trials for Sirolimus (DB00877)

Indication	Status	Phase
DBCOND0028499 (Recurrent Adult Diffuse Small Cleaved Cell Lymphoma)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00105001	Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer	Treatment	Fludarabine (DB01073) Mycophenolate mofetil (DB00688) Sirolimus (DB00877) Tacrolimus (DB00864)